Umbilical cord tissue (Wharton's Jelly) as an MSC source

Culture geometry and media composition are not the only manufacturing variables that determine what an MSC preparation contains. The tissue the cells come from matters too, and the literature treats umbilical cord tissue, amniotic tissue, adipose tissue, and bone marrow as distinct sources, not interchangeable inputs to the same process.

What Wharton's Jelly is

Wharton's Jelly is the gelatinous connective tissue surrounding the blood vessels of the umbilical cord. It has been used as an MSC source since it was first characterized for that purpose in the early 1990s. Umbilical cord tissue is collected after a full-term birth, from tissue that is otherwise discarded, and does not require an invasive procedure on a living donor.

How common source tissues compare

Cord tissue and amniotic tissue are both perinatal sources but they are not the same tissue and are not interchangeable in the literature. Adult sources (adipose, bone marrow) come from donors who have accumulated years of environmental exposure; the published literature documents donor-age and tissue-of-origin variability in MSC proliferative capacity and secretory profile from adult sources. Perinatal sources are collected at a single, standardized developmental timepoint.

Protein-level evidence: umbilical cord tissue MSC secretome, 3D vs 2D

Santos et al. (2015) compared the secretome of human umbilical cord tissue-derived MSCs (UCX cells) grown as 3D spheroids against the same cells in 2D monolayer, with matched cell numbers, conditioning volume, and conditioning time. Factors were measured directly in the conditioned medium by bead-based immunoassay, not inferred from gene expression:

The KGF result is a useful caution: 3D culture does not uniformly raise every secreted factor. This is a factor-specific shift, documented at the protein level, and specific to umbilical cord tissue MSCs, not a study of adipose, bone marrow, or amniotic cells.

Gene expression evidence: Wharton's Jelly MSCs in scaffold-free 3D culture

Thakur et al. (2022) studied Wharton's Jelly MSCs specifically in scaffold-free 3D conditions. The reported increases in VEGF, IL-10, LIF, ANG1, and IDO were measured primarily by RT-qPCR, meaning gene transcription, not directly measured secreted protein in the conditioned medium. Read this as gene-expression evidence of the same general pattern the Santos study documents at the protein level, not as a second protein-level confirmation of the same numbers.

Yield evidence: exosomes from 3D-cultured umbilical cord tissue MSCs

Two independent groups report higher exosome yield per cell from 3D-cultured umbilical cord tissue MSCs relative to matched 2D culture of the same cell type: Yan and Wu (2020), using a hollow-fiber bioreactor, and Haraszti et al. (2018), using tangential flow filtration. Haraszti et al. is also cited on this site's 3D vs 2D culture and research pages for its yield data; its source cells are human umbilical cord-derived MSCs, stated explicitly here since source tissue is this page's subject. Full citations are in the research library.

Why source tissue matters when reading the literature

When reviewing evidence for any MSC or exosome preparation, check whether the cited studies used the same source tissue as the preparation in question. A finding demonstrated with adipose-derived MSCs is evidence about adipose-derived MSCs. It does not automatically transfer to a preparation from umbilical cord tissue, and the reverse is equally true. The literature curated on this site notes source tissue explicitly wherever it differs from umbilical cord tissue, rather than presenting all MSC studies as a single undifferentiated body of evidence.

Further reading

• 3D vs 2D culture →
• The MSC secretome →
• Curated peer-reviewed citations, including full references for the studies above →